Sg Americas Securities, LLC Atai Life Sciences N.V. Transaction History
Sg Americas Securities, LLC
- $29.7 Billion
- Q3 2025
A detailed history of Sg Americas Securities, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 53,477 shares of ATAI stock, worth $213,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,477
Previous 11,456
366.8%
Holding current value
$213,908
Previous $25,000
1032.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ATAI
# of Institutions
149Shares Held
45.8MCall Options Held
1.88MPut Options Held
543K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$21.7 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.15 Million12.47% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...